# DermCareAI — Production Completion Review
**Review date:** 2026-11-06  
**Repository:** `drkvvk2015/DermCareAI_ONE`  
**Baseline:** `main` at `f3818f68c957fb8a2b981b335cce85430c185ccc`

This review tracks the six completion workstreams. It deliberately separates repository changes from decisions and evidence that must come from the deploying clinic.

## 1. Branch and pull-request consolidation

- Only PR #233 was open at review time.
- Candidate branches checked included `swarm/mobile-clinical-flow-v4` (1 commit ahead / 142 behind), `swarm/dermatology-full-e2e-v4` (2 ahead / 142 behind), `swarm/final-dispense-ledger-integration-v7` (1 ahead / 100 behind), and `swarm/pharmacy-concurrency-hardening-v8` (4 ahead / 99 behind).
- Those branches contain narrow changes, not a current, merge-ready integration. Blindly merging them risks reintroducing stale code over the consolidated PWA/Capacitor architecture.
- Action: preserve the branches, port only independently reviewed changes onto current `main`, and require current CI plus staging evidence for each port.

## 2. CI and native packaging

- The previous native validation attempted `npx cap add` / `npx cap sync` and failed with “could not determine executable to run”.
- Repair branch now invokes the installed, lockfile-pinned Capacitor CLI by its package entrypoint and explicitly installs development dependencies.
- This is a proposed fix until GitHub Actions reruns Android and iOS generation/sync on the repair PR.

## 3. Dependency security

The 2026-11-02 audit artifact recorded two high-severity npm findings and Python vulnerabilities in both runtime and CI lock graphs.

| Package | Audited lock version | Patched floor |
|---|---:|---:|
| vite | 6.4.3 | 6.4.5 |
| re2js | 2.8.6 | 2.8.7 |
| Pillow | 12.3.0 | 13.0.0 |
| pyasn1 | 0.6.4 | 0.6.5 |
| filelock | 4.0.10 | 4.2.1 |
| certifi | 2026.7.22 | 2026.10.19 |
| opentelemetry-api | 1.45.0 | 1.45.1 |
| setuptools | 84.0.0 | 84.1.0 |

- Python source requirement inputs now declare the patched floors.
- Dependabot now scans `/webapp` and `/backend`, instead of the obsolete `/dermcareai` path.
- Expired Expo-specific audit exceptions were removed; no exception is being used to hide a fixable finding.
- A lock-refresh workflow regenerates npm and hash-locked Python lockfiles, audits them, and creates a reviewed dependency PR on scheduled/manual runs.
- Completion criterion: updated lockfiles committed and a fresh dependency audit passes. Until then, dependency security remains a release blocker.

## 4. Clinical workflow completeness

The current migration acceptance document explicitly limits the current PWA release. The following should not be advertised as complete until implemented and tested end-to-end:

- encounter creation/editing and clinician sign-off in the PWA;
- lesion body-map capture and longitudinal lesion workflow;
- prescription creation/editing and dispensing linkage;
- appointments;
- billing UI/workflow;
- pharmacy UI/workflow.

The backend contains domain modules and APIs, but that does not prove complete end-user workflows. These need separate implementation PRs, synthetic-data integration tests, and clinical acceptance.

## 5. Patient privacy operations

The existing privacy runbook correctly states that full export, coordinated deletion across databases/providers, and automatic retention/deletion are not implemented. These need an approved clinic data map, retention/legal-hold policy, provider deletion contracts, named privacy owner, and dual-reviewed operational procedures. No destructive patient-data endpoint should be added before those contracts exist.

## 6. Clinical AI, regulatory and production deployment

The diagnostic model remains evidence-gated. Independent/prospective clinical validation, model calibration/subgroup/OOD evidence, intended-use and CDSCO assessment, applicable DPDP/privacy review, clinic approvals, production infrastructure/secrets, and accountable go-live approval cannot be manufactured by a code change. Keep diagnostic inference disabled and continue to label assistive output as suggestions only.

## Release disposition

**Not approved for real-patient production use on the evidence currently available.** Software CI, dependency audit, privacy operations, clinical validation, regulatory review, and cloud deployment are separate gates. Reassess only when each completion criterion has dated evidence and an accountable owner.
